Sintilimab for the treatment of lung adenocarcinoma-induced immune-related hypophysitis: a case report

Sintilimab for the treatment of lung adenocarcinoma-induced immune-related hypophysitis: a case report

Immune checkpoint inhibitors (ICIs) are extensively utilized in the treatment of oncological patients, and the immune-related adverse reactions they induce merit close monitoring. This report describes a case of a lung cancer patient who, after receiving chemotherapy in combination with the programm...

Full description

Saved in:
Bibliographic Details
Main Authors: Ming-xing Wang, Ai-xin Liu, Qing-ming Sun, Wan-hui Dong
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
sintilimab
hypophysitis
diabetes insipidus
adverse reactions
immune checkpoint inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1534179/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items